Share Your Research, Maximize Your Social Impacts
Main Menu
Searching By
PARTNERS
2020 - LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers
Date2020-07-10
Deadline2020-07-10
VenueOnline, Canada 
KeywordsPreclinical; Mass Spectrometry; Pharmacokinetic
Websitehttps://xtalks.com
Topics/Call fo Papers
In this webinar, participants will learn about:
LBA vs Hybrid LCMS
Advantages of using LBA
Advantages of using Hybrid LCMS
How to choose which approach to use (LBA or MS)
Case studies highlighting the advantage of each technology and case studies where an alternate technology was necessary
LBA vs Hybrid LCMS
Advantages of using LBA
Advantages of using Hybrid LCMS
How to choose which approach to use (LBA or MS)
Case studies highlighting the advantage of each technology and case studies where an alternate technology was necessary
Other CFPs
- The Future of Medical Devices: How COVID-19 and the Rise of Digital Health has changed Regulatory, Clinical, and Reimbursement Dynamics in the Medical Device Industry
- Achieving High Performance Study Start-up: An Inside Look at GSK
- Successfully Navigating Cost Barriers to Deliver Low Cost Connectivity to the Pharmaceutical Industry
- CRISPR Generated Models: A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services
- Leadership Development for Executive Assistants
Last modified: 2020-07-08 05:46:13